Vaccination with EGF active immunotherapy improves survival in advanced non small cell lung cancer (NSCLC) patients: Interim analysis of a randomized phase II trial

Elia Neninger,Tania Crombet,Marta Osorio,M. Catala,Ana de la Torre,I. Leonard,Beatriz Garcia,P. Marinello,G. Gonzalez,Agustin Lage

Vaccination with EGF active immunotherapy improves survival in advanced non small cell lung cancer (NSCLC) patients: Interim analysis of a randomized phase II trial

2005

Elia Neninger
Tania Crombet
Marta Osorio
M. Catala
Ana de la Torre
I. Leonard
Beatriz Garcia
P. Marinello
G. Gonzalez
Agustin Lage

7210 Background: During the last 9 years, numerous clinical trials have been conducted testing an Epidermal Growth Factor (EGF) active immunotherapy approach in patients with advanced NSCLC. This a...

Keywords:

Vaccination
Pathology
non-small cell lung cancer (NSCLC)
Immunology
Interim analysis
Active immunotherapy
Medicine
Internal medicine
Epidermal growth factor
in patient
Oncology
Clinical trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations